Understanding PP and treatment of HypoPP Biannual Meeting of the PPA Orlando, FL, 2011 Frank...

19
Understanding PP and treatment of HypoPP Biannual Meeting of the PPA Orlando, FL, 2011 Frank Lehmann-Horn, Senior Research Professor

Transcript of Understanding PP and treatment of HypoPP Biannual Meeting of the PPA Orlando, FL, 2011 Frank...

Understanding PPand

treatment of HypoPP

Biannual Meeting of the PPA Orlando, FL, 2011

Frank Lehmann-Horn, Senior Research Professor

Electrical potentials P of skeletal muscle fibers

P-values around -83 mV are most frequent (P1)

Second fraction around -60 mV (P2)

P is about 1/100 of the voltage of a car battery

K+ Battery

P1

-90 -80 -70 -60 (mV)

P2

Dis

trib

utio

n fr

eque

ncy

%

Muscle strength dependent on resting potential P

Muscle fibers

-90mV

-73 mV

-65 mV

-55 mVDepolarized fibers can´t develop force

Simple basis of PP weakness:Many fibers are episodically or permanently in the P2-state

prevalence: 1:100,000; dominant transmission

onset of disease: childhood or puberty

clinical features: weakness episodes (at younger age) and/orpermanent weakness, a progressive myopathy

weakness episodes: up to daily for several hours

Provocative factors: carbohydrates, sodium, resting periods after exercise, mental stress, cooling, fever, cortisol induce a drop in serum potassium

between episodes: blood potassium is normal

etiology: voltage sensor mutations (Na+, Ca2+ channels)

Hypokalemic Periodic Paralysis (HypoPP)

HypoPP mutations are situated in S4 only and cause Na+ leak

Due to the membrane leak of the accessory Na+ pore, the resting potential drops to approx. -58 mV at which fibers are paralyzed

VSD

III

III IV

Central pore

Accessory Na+ pore along mutant S4

S4

Calcium or sodium channelsituated in the cell membrane

Weak after carb-rich meal

-90 -80 -70 -60 -50 -400.00

0.04

0.08pr

obab

ility

den

sity

(m

V-1)

Em (mV)

P1

P2

P2

P1

-110 -100 -90 -80 -70 -60 -500.00

0.01

0.02

0.03

0.04

0.05

0.06

0.07

Em /mvUsually strongP2-fraction explains full-blown attack

hypokalemia opens Na+ pore

Periodic paralysis: permanent weakness

large P2-fraction explains perma-nent weakness

-90 -80 -70 -60 (mV)

P1

P2

Does the accessory pore really con-duct Na+? More Na+ in the fibers?

HypoPP with permanent weakness: dystrophy, edema and intracellular Na+ accumulation

1H-T1 23Na-IR1H-T2-STIR

NaCl solution

NaCl inagarose

Novel technique: 23Na-MRI IRControl: low muscle Na+

i content

P1

P2

-90 -80 -70 -60 (mV)

P1

P2

-90 -80 -70 -60

VolunteerStrength improved

by K+ and AA or CAI

(mV)-90 -80 -70 -60 (mV)

P1

P2

permanent weakness (large P2-fraction)

Therapy: shifting fibers from the P2- to the P1-state

control

untreated patient

Control

HypoPP before treatment

HypoPP during treatment

Jurkat-Rott et al. PNAS 2009

Therapy: reduction of edema and Na+ overload

Therapy also increases muscle strength

0,9

1

1,1

1,2

1,3

1,4

1,5

1,6

17 22 27 32

Na+ / mM

rela

tive

str

eng

th in

crea

se p

ost

/pre

tre

atm

ent

after therapy (acetazolamide)

before therapy

Jurkat-Rott et al. PNAS 2009

After 6 months of therapybefore therapy

Response to an aldosterone antagonist

Hypothesis: development of muscle dystrophy

normalfull muscle strength

intracellular Na+ accumulation and edemareversible weakness

fibrosis and fatty replacementirreversible weakness

triggers CAI, aldosterone Antagonists, K+

25 y.

52 y.

80 y.

HypoPP family

with years

Drugs which stabilize muscle fibers in the P1 state

Potassium (fast & slow release)

Carbonic anhydrase inhibitors- Acetazolamide (Diamox)- Diclofenamide (Daranide)

Aldosterone antagonists- Spironolactone (Aldactone)- Eplerenone (Inspra)

Potassium-sparing diuretics- Triamterene (Dyrenium)- Amiloride (Midamor)

Potassium channel opener- Retigabine

Delayed K-channel blocker- 3,4-diaminopyridine; 3,4-DAP

At permanent weakness, continuous ingestion is required

Diet: high-K, low NaCl-saltlow carbohydrate

Similar MRI results for Duchenne muscular dystrophy as for PP – synergic therapeutical efforts

dystrophin deficiency

1:3,500 male births

rapid progression of skeletal muscle dystrophyand cardiomyopathy

corticoid treatment

T1w STIR

Na-IR: intracellular Na+

DMD boy at age of 7 years: minor degeneration, however: already severe edema and intracelluar Na accumulation

!

T1w STIR

[Na+]

DMD boy at age of 10 years: moderate degeneration and still severe edema and intracelluar Na accumulation

Na accumulation and edema preceed/cause degeneration

Na-IR: intracellular Na+

Thanks to Karin Jurkat-Rott (Ulm), Marc-André Weber (Heidelberg), & Eva Luise Köhler

View from Ulm University of Ulm Munster and the Alpes